Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients (Q37211151)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 May 2009
edit
Language Label Description Also known as
English
Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients
scientific article published on 21 May 2009

    Statements

    Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients (English)
    0 references
    0 references
    Christian Noël
    Dominique Durand
    Michèle Kessler
    Bernard Charpentier
    François Berthoux
    Pierre Merville
    Jean-Paul Squifflet
    François Bayle

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit